Cargando…
Is hemolysis a novel therapeutic target in COVID-19?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438449/ https://www.ncbi.nlm.nih.gov/pubmed/36059481 http://dx.doi.org/10.3389/fimmu.2022.956671 |
| _version_ | 1784781826898788352 |
|---|---|
| author | Ousaka, Daiki Nishibori, Masahiro |
| author_facet | Ousaka, Daiki Nishibori, Masahiro |
| author_sort | Ousaka, Daiki |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9438449 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94384492022-09-03 Is hemolysis a novel therapeutic target in COVID-19? Ousaka, Daiki Nishibori, Masahiro Front Immunol Immunology Frontiers Media S.A. 2022-08-19 /pmc/articles/PMC9438449/ /pubmed/36059481 http://dx.doi.org/10.3389/fimmu.2022.956671 Text en Copyright © 2022 Ousaka and Nishibori https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Immunology Ousaka, Daiki Nishibori, Masahiro Is hemolysis a novel therapeutic target in COVID-19? |
| title | Is hemolysis a novel therapeutic target in COVID-19? |
| title_full | Is hemolysis a novel therapeutic target in COVID-19? |
| title_fullStr | Is hemolysis a novel therapeutic target in COVID-19? |
| title_full_unstemmed | Is hemolysis a novel therapeutic target in COVID-19? |
| title_short | Is hemolysis a novel therapeutic target in COVID-19? |
| title_sort | is hemolysis a novel therapeutic target in covid-19? |
| topic | Immunology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438449/ https://www.ncbi.nlm.nih.gov/pubmed/36059481 http://dx.doi.org/10.3389/fimmu.2022.956671 |
| work_keys_str_mv | AT ousakadaiki ishemolysisanoveltherapeutictargetincovid19 AT nishiborimasahiro ishemolysisanoveltherapeutictargetincovid19 |